
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2025 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2025 Earnings Call Transcript May 7, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.55. Operator: Good afternoon, and welcome to the Quarter One 2025 …